OROFER FCM 500MG INJ.

Product Description for OROFER FCM 500MG Injection (B2B Market)

Brand Name: OROFER FCM
Strength: 500 mg
Form: Injection
Therapeutic Category: Iron Supplement, Hematologic Agent
Manufacturer: [Manufacturer Name]
Pack Size: Vial (1 vial per pack)

Indication:
OROFER FCM 500mg Injection is used for the treatment of iron deficiency anemia in patients who are unable to tolerate oral iron supplements or have not responded adequately to oral iron therapy. It is particularly beneficial for patients with:

• Iron Deficiency Anemia
• Chronic Kidney Disease (CKD)
• Gastrointestinal conditions (e.g., malabsorption, gastric bypass)
• Pregnancy-related anemia
• Post-surgical recovery
• Other conditions where oral iron supplementation is ineffective or insufficient.

OROFER FCM (Ferric Carboxymaltose) is a parenteral iron formulation used to quickly restore iron levels in patients suffering from iron deficiency anemia.

Mechanism of Action:
OROFER FCM contains Ferric Carboxymaltose, a complex of iron (III) and a carbohydrate that allows for controlled release of iron, which can be effectively absorbed by the body. Once injected, ferric carboxymaltose releases iron ions that are transported to the bone marrow, where they are used to produce hemoglobin and red blood cells. This helps correct iron deficiency and the symptoms of anemia, improving oxygen transport throughout the body.

Dosage and Administration:
OROFER FCM 500mg Injection is administered as an intravenous (IV) infusion or slow IV push, depending on the patients condition and the healthcare providers recommendation. The typical dose for an adult patient depends on the severity of iron deficiency, body weight, and hemoglobin levels.

Key Features:

• Fast-Acting: Provides rapid restoration of iron stores in patients, with noticeable improvements in anemia-related symptoms.
• Convenient Dosage: Can be administered in a single dose or in multiple sessions, depending on individual needs.
• High Tolerability: Generally well-tolerated with a low incidence of side effects, compared to other forms of intravenous iron.
• Efficient Iron Delivery: Uses a formulation designed for optimal absorption and reduced risk of iron overload.
• Safe for Special Populations: Can be used in pregnant women and individuals with chronic kidney disease, under medical supervision.

Packaging:
Each vial contains 500 mg of Ferric Carboxymaltose in sterile solution for intravenous infusion. Available in packs of [insert number] vials per box.

Storage Instructions:

• Store at 2C to 8C (36F to 46F).
• Do not freeze.
• Keep in the original carton to protect from light.

Contraindications:

• Known hypersensitivity to Ferric Carboxymaltose or any component of the formulation.
• Active or recent history of iron overload (e.g., hemochromatosis, hemosiderosis).
• Uncontrolled infections.
• Anemia not due to iron deficiency.

Side Effects:
Common side effects may include headache, nausea, dizziness, and injection site reactions (pain, redness, swelling). Serious side effects may include allergic reactions, hypotension, or iron overload (in rare cases, with improper dosing).

Regulatory Status:
Approved by [Relevant Health Authority/Agency].

For wholesale inquiries, distribution, or B2B partnerships, please contact our sales team at [Contact Details].

Note: Always consult with a healthcare provider for proper diagnosis and treatment before administering OROFER FCM 500mg Injection.